DSM has reported strong results with solid growth for the second quarter. With continuing operations DSM saw a healthy €339 million (US$480.787 million) which was higher than 2010 and early 2011. DSM reports that the Martek integration on track and showed an excellent Q2 EBITDA performance. Furthermore EPS more than doubled, reflecting strong operating results, lower tax rate and one-off gains.
“However, we believe we are well positioned with our balanced, relatively resilient portfolio in health, nutrition and materials, and with our broad geographic footprint, strong technology and leading market positions. Read more ...
This blog is written by Martin Little, The Global Miller, published and supported by the GFMT Magazine and the International Milling Directory from Perendale Publishers
No comments:
Post a Comment